| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/13/2007 | CA2644850A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644166A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases |
| 09/12/2007 | EP1832586A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas |
| 09/12/2007 | EP1832585A1 Thiazole-piperidine derivatives for treatment of hyperproliferative diseases |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831207A1 Aminopyrimidine compounds and methods of use |
| 09/12/2007 | EP1831197A2 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 09/12/2007 | EP1831195A1 5-ht7 receptor antagonists |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 09/12/2007 | EP1831183A1 1,6-substituted (3r,6r)-3-(2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1830848A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1558580B1 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 09/12/2007 | EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | CN101035795A Thiazolyl-dihydro indazoles |
| 09/12/2007 | CN101035785A Novel compounds having an anti-bacterial activity |
| 09/12/2007 | CN101035775A New hydroxymethylbenzothiazoles amides |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/07/2007 | WO2007101213A2 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100851A1 Therapeutic compounds |
| 09/07/2007 | WO2007100739A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | WO2007100646A1 Multi-cyclic compounds and method of use |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007100027A1 Optically active thiazolidinedione derivative |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2644068A1 Therapeutic compounds |
| 09/07/2007 | CA2643323A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2642424A1 Primary amines as renin inhibitors |
| 09/07/2007 | CA2638734A1 Inhibitors of the unfolded protein response and methods for their use |
| 09/06/2007 | US20070208182 Zwitterionic Non-Linear Optophores And Devices Incorporating Same |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208068 Aqueous Composition Comprising Thiazole Derivative |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208035 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208021 Phenoxyacetic Acid Derivatives and Drug Comprising The Same |
| 09/06/2007 | US20070208015 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators |
| 09/06/2007 | US20070208012 Modulation of Pathogenicity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070207994 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207985 treating diabetes, hyperglycemia, obesity, dyslipidemia, and hypertension; compounds are based on 1,2,4-triazine and fused ring derivatives thereof, for example 3-Adamantan-1-yl-5,6-dimethyl-1,2,4-triazine |
| 09/05/2007 | EP1829865A2 Chemical compounds |
| 09/05/2007 | EP1829549A1 Amorphous composition |
| 09/05/2007 | EP1828178A1 Process for preparation of high-purity meloxicam and meloxicam potassium salt |
| 09/05/2007 | EP1828177A2 Novel mch receptor antagonists |
| 09/05/2007 | EP1828176A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/05/2007 | EP1828165A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828124A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1567490A4 Anti-sickling agents |
| 09/05/2007 | EP1521753B1 A process to prepare pioglitazone via several intermediates. |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1345598B1 The use of rosiglitazone for treating psychiatric disorders. |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031566A Proline derivatives |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031558A HIV inhibiting 5-heterocyclyl pyrimidines |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101031295A Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 09/05/2007 | CN101029048A Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN100335491C Macrolide compounds endowed with antiinflammatory activity |
| 09/05/2007 | CN100335478C Chemokine receptor binding heterocyclic compounds |
| 09/04/2007 | US7265152 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 09/04/2007 | US7265140 E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria |
| 09/04/2007 | US7265139 RXR activating molecules |
| 09/04/2007 | US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 09/04/2007 | US7265134 Tyrosine kinase inhibitors |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265123 Heterocyclic compounds |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265109 Thiazole derivatives |
| 09/04/2007 | US7264891 Stability, efficiency and color purity |
| 09/04/2007 | CA2274063C Substituted pyrimidine compounds and their use |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |